Search

Megan Smutzer Phones & Addresses

  • 1716 Royce Ave, Kalamazoo, MI 49001
  • Fort Dodge, IA
  • Davenport, IA
  • Ames, IA

Work

Company: Zoetis Dec 2013 to Jun 2016 Position: Senior associate scientist

Education

Degree: Bachelors, Bachelor of Science School / High School: Iowa State University 2004 to 2008 Specialities: Genetics

Skills

Vaccines • Clinical Trials • Cell Culture • Molecular and Cellular Biology • Bacteriology • Clinical Data Management • Assay Development • Downstream Processing • Elisa • Polymerase Chain Reaction • Validation • Cell Biology

Industries

Pharmaceuticals

Resumes

Resumes

Megan Smutzer Photo 1

Scientist

View page
Location:
1716 Royce Ave, Kalamazoo, MI 49001
Industry:
Pharmaceuticals
Work:
Zoetis Dec 2013 - Jun 2016
Senior Associate Scientist

Zoetis Dec 2013 - Jun 2016
Scientist

Zoetis Jun 2013 - Dec 2013
Associate Scientist

Pfizer Jan 2010 - Dec 2013
Associate Scientist

Fort Dodge Animal Health Jan 2009 - Jan 2010
Scientist
Education:
Iowa State University 2004 - 2008
Bachelors, Bachelor of Science, Genetics
Assumption High School Davenport, Ia
Skills:
Vaccines
Clinical Trials
Cell Culture
Molecular and Cellular Biology
Bacteriology
Clinical Data Management
Assay Development
Downstream Processing
Elisa
Polymerase Chain Reaction
Validation
Cell Biology

Publications

Us Patents

Pcv/Mycoplasma Hyopneumoniae Combination Vaccine

View page
US Patent:
20130266602, Oct 10, 2013
Filed:
Mar 26, 2013
Appl. No.:
13/850329
Inventors:
Gregory P. Nitzel - Mattawan MI, US
Jeffrey E. Galvin - Lincoln NE, US
John Keith Garrett - Lincoln NE, US
Tracy L. Ricker - Portage MI, US
Megan Marie Smutzer - Kalamazoo MI, US
Assignee:
Zoetis LLC - Florham Park NJ
International Classification:
A61K 39/295
US Classification:
4241861, 4242011
Abstract:
This invention provides a multivalent immunogenic composition including a soluble portion of a () whole cell preparation; and a porcine circovirus type 2 (PCV2) antigen, wherein the soluble portion of the preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Mycoplasma Hyopneumoniae Vaccine

View page
US Patent:
20130266601, Oct 10, 2013
Filed:
Mar 26, 2013
Appl. No.:
13/850318
Inventors:
Jeffrey E. Galvin - Lincoln NE, US
Gregory P. Nitzel - Mattawan MI, US
John Keith Garrett - Lincoln NE, US
Tracy L. Ricker - Portage MI, US
Megan Marie Smutzer - Kalamazoo MI, US
Assignee:
Zoetis LLC - Florham Park NJ
International Classification:
C07K 14/30
A61K 39/02
A61K 39/295
US Classification:
4241861, 4242641, 4242011, 4241901
Abstract:
This invention provides an immunogenic composition including a soluble portion of a (M.hyo) whole cell preparation, wherein the soluble portion of the M.hyo preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Pcv/Mycoplasma Hyopneumoniae/Prrs Combination Vaccine

View page
US Patent:
20130266603, Oct 10, 2013
Filed:
Mar 26, 2013
Appl. No.:
13/850331
Inventors:
Gregory P. Nitzel - Mattawan MI, US
Jeffrey E. Galvin - Lincoln NE, US
John Keith Garrett - Lincoln NE, US
Tracy L. Ricker - Portage MI, US
Megan Marie Smutzer - Kalamazoo MI, US
Assignee:
Zoetis LLC - Florham Park NJ
International Classification:
A61K 39/295
US Classification:
4241861, 4242011
Abstract:
This invention provides a trivalent immunogenic composition including a soluble portion of a () whole cell preparation; a porcine circovirus type 2 (PCV2) antigen; and a PRRS virus antigen, wherein the soluble portion of the preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Pcv/Mycoplasma Hyopneumoniae Vaccine

View page
US Patent:
20200338187, Oct 29, 2020
Filed:
Apr 28, 2020
Appl. No.:
16/860308
Inventors:
- Parsippany NJ, US
Jeffrey E. Galvin - Lincoln NE, US
John Keith Garrett - North Wilkesboro NC, US
Tracy L. Ricker - Portage MI, US
Megan Marie Smutzer - Kalamazoo MI, US
International Classification:
A61K 39/12
A61K 39/295
A61K 39/02
C12N 7/00
Abstract:
This invention provides a combination vaccine which includes a porcine circovirus type 2 (PCV2) antigen and a cell free (M.hyo) culture supernatant for protecting a pig against PCV2 and M.hyo infections, wherein the M.hyo culture supernatant is substantially free of PCV2 antibodies.

Mycoplasma Hyopneumoniae Vaccine

View page
US Patent:
20200330577, Oct 22, 2020
Filed:
Apr 27, 2020
Appl. No.:
16/859093
Inventors:
- Parsippany NJ, US
Gregory P. Nitzel - Paw Paw MI, US
John Keith Garrett - North Wilkesboro NC, US
Tracy L. Ricker - Portage MI, US
Megan Marie Smutzer - Kalamazoo MI, US
International Classification:
A61K 39/02
C07K 14/30
A61K 39/295
A61K 39/12
C12N 1/36
A61K 39/39
Abstract:
This invention provides a (M.hyo) antigen that is compatible with antigens from other swine pathogens, wherein the M.hyo antigen is a cell free M.hyo culture supernatant which is substantially free of swine IgG.

Pcv/Mycoplasma Hyopneumoniae Vaccine For Use With Prrsv Vaccine

View page
US Patent:
20190209673, Jul 11, 2019
Filed:
Jan 15, 2019
Appl. No.:
16/248239
Inventors:
- Parsippany NJ, US
Jeffrey E. Galvin - Lincoln NE, US
John Keith Garrett - North Wilkesboro NC, US
Tracy L. Ricker - Portage MI, US
Megan Marie Smutzer - Kalamazoo MI, US
International Classification:
A61K 39/12
A61K 39/295
A61K 39/02
C12N 7/00
Abstract:
This invention provides a combination of a first vaccine comprising a porcine circovirus type 2 (PCV2) antigen and a () culture supernatant and a second vaccine comprising a porcine reproductive and respiratory syndrome (PRRS) virus antigen, for treating an animal against an infection with PCV2, an infection with , and an infection with PRRS virus, wherein the culture supernatant has been separated from insoluble cellular material and is substantially free of both IgG and immunocomplexes comprised of antigen bound to immunoglobulin.

Pcv/Mycoplasma Hyopneumoniae/Lawsonia Intracellularis Combination Vaccine

View page
US Patent:
20170216423, Aug 3, 2017
Filed:
Apr 6, 2017
Appl. No.:
15/480973
Inventors:
- Parsippany NJ, US
Jeffrey E. Galvin - Lincoln NE, US
John Keith Garrett - North Wilkesboro NC, US
Tracy L. Ricker - Portage MI, US
Megan Marie Smutzer - Kalamazoo MI, US
International Classification:
A61K 39/12
C12N 7/00
A61K 39/02
Abstract:
This invention provides a multivalent immunogenic composition including a soluble portion of a (M.hyo) whole cell preparation; a porcine circovirus type 2 (PCV2) antigen; and a antigen, wherein the soluble portion of the M.hyo preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Mycoplasma Hyopneumoniae Vaccine

View page
US Patent:
20170209560, Jul 27, 2017
Filed:
Apr 6, 2017
Appl. No.:
15/480949
Inventors:
- Parsippany NJ, US
Gregory P. Nitzel - Paw Paw MI, US
John Keith Garrett - North Wilkesboro NC, US
Tracy L. Ricker - Portage MI, US
Megan Marie Smutzer - Kalamazoo MI, US
International Classification:
A61K 39/02
A61K 39/39
Abstract:
This invention provides an immunogenic composition including the supernatant of a (M.hyo) culture, wherein the supernatant of the M.hyo culture has been separated from insoluble cellular material by centrifugation, filtration, or precipitation and is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.
Megan M Smutzer from Kalamazoo, MI, age ~39 Get Report